Cargando…

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance

BACKGROUND: Myocardial scarring at the LV pacing site leads to incomplete resynchronization and a suboptimal symptomatic response to CRT. We sought to determine whether the use of late gadolinium cardiovascular magnetic resonance (LGE-CMR) to guide left ventricular (LV) lead deployment influences th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leyva, Francisco, Foley, Paul WX, Chalil, Shajil, Ratib, Karim, Smith, Russell EA, Prinzen, Frits, Auricchio, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141552/ https://www.ncbi.nlm.nih.gov/pubmed/21668964 http://dx.doi.org/10.1186/1532-429X-13-29

Ejemplares similares

Left ventricular non-compaction: clinical features and cardiovascular magnetic resonance imaging
por: Yousef, Zaheer R, et al.
Publicado: (2009)

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Electrical and Mechanical Ventricular Activation During Left Bundle Branch Block and Resynchronization
por: Strik, Marc, et al.
Publicado: (2012)

Cardiac resynchronization therapy guided by cardiovascular magnetic resonance
por: Leyva, Francisco
Publicado: (2010)

What is treatment success in cardiac resynchronization therapy?
por: Foley, Paul W.X., et al.
Publicado: (2009)

The evolving state of cardiac resynchronization therapy and conduction system pacing: 25 years of research at EP Europace journal
por: Ellenbogen, Kenneth A, et al.
Publicado: (2023)

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy
por: Leyva, Francisco, et al.
Publicado: (2018)

Plasma Extracellular Vesicles as Liquid Biopsy to Unravel the Molecular Mechanisms of Cardiac Reverse Remodeling Following Resynchronization Therapy?
por: van Nieuwenhoven, Frans A., et al.
Publicado: (2023)

Radial dyssynchrony assessed by cardiovascular magnetic resonance in relation to left ventricular function, myocardial scarring and QRS duration in patients with heart failure
por: Foley, Paul WX, et al.
Publicado: (2009)

The “Missing” Link Between Acute Hemodynamic Effect and Clinical Response
por: Prinzen, Frits W., et al.
Publicado: (2011)

Synchronization of repolarization after cardiac resynchronization therapy: A combined clinical and modeling study
por: Verzaal, Nienke J., et al.
Publicado: (2022)

Mechano-energetics of the asynchronous and resynchronized heart
por: Prinzen, Frits W., et al.
Publicado: (2010)

Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy
por: Maffessanti, Francesco, et al.
Publicado: (2022)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
por: Lossnitzer, Dirk, et al.
Publicado: (2010)

Dressler's syndrome demonstrated by late gadolinium enhancement cardiovascular magnetic resonance
por: Steadman, Christopher D, et al.
Publicado: (2009)

Erratum to: Mechano-energetics of the asynchronous and resynchronized heart
por: Prinzen, Frits W., et al.
Publicado: (2011)

Histopathological Validation of Dark‐Blood Late Gadolinium Enhancement MRI Without Additional Magnetization Preparation
por: Holtackers, Robert J., et al.
Publicado: (2021)

Long‐Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular Pacing
por: Leyva, Francisco, et al.
Publicado: (2018)

Predictive Value of Left Atrial Remodeling for Response to Cardiac Resynchronization Therapy
por: Bouwmeester, Sjoerd, et al.
Publicado: (2022)

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy
por: Foley, Paul W.X., et al.
Publicado: (2009)

Histopathological validation of semi-automated myocardial scar quantification techniques for dark-blood late gadolinium enhancement magnetic resonance imaging
por: Nies, Hedwig M J M, et al.
Publicado: (2022)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Assessment of Substrate for Ventricular Tachycardia With Hemodynamic Compromise
por: Whitaker, John, et al.
Publicado: (2021)

Vectorcardiographic QRS area as a predictor of response to cardiac resynchronization therapy
por: Ghossein, Mohammed A, et al.
Publicado: (2022)

Atrioventricular dromotropathy: an important substrate for complete resynchronization therapy—Authors’ reply
por: Salden, Floor C W M, et al.
Publicado: (2022)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
por: Strijack, Bradford, et al.
Publicado: (2008)

Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance
por: Lopez, Javier E, et al.
Publicado: (2009)

Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance
por: Quail, Michael, et al.
Publicado: (2019)

Life-threatening pericardial bleed complicating atrial fibrillation ablation associated with edoxaban therapy successfully managed with prothrombin complex concentrate
por: Choudhury, Moinuddin, et al.
Publicado: (2019)

Left ventricular internal flow fraction from cardiac magnetic resonance images is higher in patients who respond to cardiac resynchronization therapy
por: Clement-Guinaudeau, Stephanie, et al.
Publicado: (2012)

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance
por: Kirk, Paul, et al.
Publicado: (2011)

Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension
por: Freed, Benjamin H, et al.
Publicado: (2012)

Late gadolinium enhancement by cardiovascular magnetic resonance provides prognostic information in symptomatic alcoholic cardiomyopathy
por: Xiangli, Wei
Publicado: (2015)

Gray blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of myocardial scar
por: Fahmy, Ahmed S., et al.
Publicado: (2018)

Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement
por: Erley, Jennifer, et al.
Publicado: (2019)

Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes
por: Domenech-Ximenos, B., et al.
Publicado: (2020)

Impact of Estimated Left Atrial Pressure on Cardiac Resynchronization Therapy Outcome
por: Beela, Ahmed S., et al.
Publicado: (2023)

Refractory hypertensive emergency associated with complete heart block resolved after permanent pacemaker implantation: A case report
por: Choudhury, Moinuddin, et al.
Publicado: (2022)

The clinical impact of late gadolinium enhancement in Takotsubo cardiomyopathy: serial analysis of cardiovascular magnetic resonance images
por: Naruse, Yoshihisa, et al.
Publicado: (2011)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_78vhpo0009tm4pd9lqkhtu97r4